...
首页> 外文期刊>Trends in Ecology & Evolution >Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli beta-glucuronidase inhibitors and their structure-inhibitory activity relationships
【24h】

Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli beta-glucuronidase inhibitors and their structure-inhibitory activity relationships

机译:噻唑胺-2-氰胺衍生物作为新型有效的大肠杆菌β-葡糖醛酸糖苷酶抑制剂及其结构抑制活性关系

获取原文
获取原文并翻译 | 示例
           

摘要

Gut microbial beta-glucuronidases have the ability to deconjugate glucuronides of some drugs, thus have been considered as an important drug target to alleviate the drug metabolites-induced gastrointestinal toxicity. In this study, thiazolidin-2-cyanamide derivatives containing 5-phenyl-2-furan moiety (1-13) were evaluated for inhibitory activity againstEscherichia coli beta-glucuronidase (EcGUS). All of them showed more potent inhibition than a commonly used positive control,d-saccharic acid 1,4-lactone, with the IC(50)values ranging from 1.2 mu M to 23.1 mu M. Inhibition kinetics studies indicated that compound1-3were competitive type inhibitors for EcGUS. Molecular docking studies were performed and predicted the potential molecular determinants for their potent inhibitory effects towards EcGUS. Structure-inhibitory activity relationship study revealed that chloro substitution on the phenyl moiety was essential for EcGUS inhibition, which would help researchers to design and develop more effective thiazolidin-2-cyanamide type inhibitors against EcGUS.
机译:肠道微生物β-葡糖醛酸酶具有欺骗某种药物的葡糖醛糖苷的能力,因此被认为是缓解药物代谢物诱导的胃肠道毒性的重要药物靶标。在该研究中,评价含有5-苯基-2-呋喃部分(1-13)的噻唑烷-2-氰胺衍生物进行抑制活性蛋白酶β-葡糖醛酸酶(ECGU)。所有这些都表现出比常用的阳性对照,D-糖酸1,4-内酯更有效的抑制作用,IC(50)值范围为1.2μm至23.1μm。抑制动力学研究表明,化合物1-3竞争ECGU的型抑制剂。进行分子对接研究,并预测潜在的分子决定因素对ECGU的有效抑制作用。结构抑制活性关系研究表明,苯基部分的氯取代对于Ecgus抑制至关重要,这将有助于研究人员设计和开发更有效的噻唑烷-2-氰胺型抑制剂对ECGUS的设计和开发更有效的噻唑烷-2-氰胺型抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号